INVOKANA 100 MG COM REV OR CT BL AL PLAS TRANS X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1123634080033 -
GGREM
514514110027202 -
Código de barras
7896212425037
O que a fonte publica
- Detentor do registro
- JANSSEN-CILAG FARMACEUTICA LTDA
- Princípios ativos
- CANAGLIFLOZINA HEMI-HIDRATADA
- Embalagem
- 100 MG COM REV OR CT BL AL PLAS TRANS X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "INVOKANA 100 MG COM REV OR CT BL AL PLAS TRANS X 30",
"holder": "JANSSEN-CILAG FARMACEUTICA LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896212425037"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "514514110027202",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "51.780.468/0001-87",
"priceRegime": "Regulado",
"productName": "INVOKANA",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "100 MG COM REV OR CT BL AL PLAS TRANS X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "144.01",
"icms-12": "163.65",
"icms-17": "173.51",
"icms-18": "175.62",
"icms-19": "177.79",
"icms-20": "180.01",
"icms-21": "182.29",
"icms-22": "184.63",
"icms-23": "187.03",
"icms-17.5": "174.56",
"icms-19.5": "178.89",
"icms-20.5": "181.14",
"icms-22.5": "185.82",
"icms-12-alc": "146.11",
"icms-17-alc": "154.92",
"icms-18-alc": "156.81",
"icms-19-alc": "158.74",
"icms-20-alc": "160.73",
"icms-21-alc": "162.76",
"icms-22-alc": "164.85",
"icms-23-alc": "166.99",
"withoutTaxes": "128.58",
"icms-17.5-alc": "155.85",
"icms-19.5-alc": "159.73",
"icms-20.5-alc": "161.74",
"icms-22.5-alc": "165.91"
},
"pisCofinsList": "Negativa",
"substanceText": "CANAGLIFLOZINA HEMI-HIDRATADA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "193.18",
"icms-12": "219.53",
"icms-17": "232.76",
"icms-18": "235.59",
"icms-19": "238.50",
"icms-20": "241.48",
"icms-21": "244.54",
"icms-22": "247.67",
"icms-23": "250.89",
"icms-17.5": "234.17",
"icms-19.5": "239.97",
"icms-20.5": "242.99",
"icms-22.5": "249.27",
"icms-12-alc": "201.99",
"icms-17-alc": "214.17",
"icms-18-alc": "216.78",
"icms-19-alc": "219.45",
"icms-20-alc": "222.20",
"icms-21-alc": "225.01",
"icms-22-alc": "227.90",
"icms-23-alc": "230.85",
"withoutTaxes": "177.75",
"icms-17.5-alc": "215.45",
"icms-19.5-alc": "220.82",
"icms-20.5-alc": "223.60",
"icms-22.5-alc": "229.36"
},
"invalidBarcodes": [],
"activeSubstances": [
"CANAGLIFLOZINA HEMI-HIDRATADA"
],
"therapeuticClass": "A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1123634080033",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A10P1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:514514110027202"